INST CANCER RES D B A THE RES INST OF FOX CHASE CANCER CT has a total of 14 patent applications. Its first patent ever was published in 2013. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and computer technology are FULCRUM THERAPEUTICS INC, XUZHOU MEDICAL COLLEGE and SHANGHAI CHUANG HONG BIOTECHNOLOGY CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Computer technology | |
#4 | Measurement | |
#5 | Organic fine chemistry | |
#6 | Foods and drinks |
# | Name | Total Patents |
---|---|---|
#1 | Bellacosa Alfonso | 3 |
#2 | Hall Michael J | 3 |
#3 | Yen Tim | 3 |
#4 | Mancuso Pietro | 3 |
#5 | Davidson Irwin | 3 |
#6 | Tricarico Rossella | 3 |
#7 | Luo Biao | 3 |
#8 | Bhattacharjee Vikram | 3 |
#9 | Yen Timothy J | 3 |
#10 | Enders Greg H | 3 |
Publication | Filing date | Title |
---|---|---|
US2015344968A1 | Methods for determining parp inhibitor and platinum resistance in cancer therapy | |
US2015242578A1 | Methods and systems for mitigating or avoiding delays in infusion room seating | |
US2015191797A1 | Systems and methods for diagnosing a predisposition to colon cancer | |
US2015184251A1 | Methods for screening muscle invasive bladder cancer patients for neoadjuvant chemotherapy responsiveness | |
US2014163028A1 | Inhibition of activated cdc42-associated kinase 1 |